We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT04751734
Previous Study | Return to List | Next Study

Impact of Maternal COVID-19 Vaccines on Breast Milk (MilkCorona)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04751734
Recruitment Status : Active, not recruiting
First Posted : February 12, 2021
Last Update Posted : March 1, 2023
Sponsor:
Collaborators:
Hospital Clínico Universitario de Valencia
Hospital Sant Joan de Deu
Hospital Universitario La Fe
Hospital Universitario Doctor Peset
Fundacion Para La Investigacion Hospital La Fe
Universitat Jaume I
University of Barcelona
Information provided by (Responsible Party):
Maria Carmen Collado, Institute of Agrochemistry and Food Technology, National Research Council

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
prospective multicenter study The main aim is to study the impact of maternal COVID-19 vaccination on breast milk immune, microbiological, and metabolic profile.

Condition or disease Intervention/treatment
COVID-19 Vaccines Biological: Covid vaccines

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Estimated Enrollment : 150 participants
Observational Model: Case-Control
Time Perspective: Prospective
Official Title: Impact of Maternal COVID-19 Vaccination on Breast Milk Antibodies, Milk Bioactive Compounds and Maternal-child Health
Actual Study Start Date : January 16, 2021
Actual Primary Completion Date : January 31, 2023
Estimated Study Completion Date : October 2023

Resource links provided by the National Library of Medicine


Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Group/Cohort Intervention/treatment
Vaccinations
SARS-CoV-2 vaccination
 Biological: Covid vaccines
women within Priority groups for coronavirus (COVID-19) vaccination


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Antibodies [ Time Frame: 1st year ]
    presence and levels of antibodies


Secondary Outcome Measures :
  1. breast milk bioactive composition [ Time Frame: 1st year ]
    immune profile (cytokines and growth factors, immunoglobulins)

  2. breast milk bioactive composition [ Time Frame: 1st year ]
    microbiota profile

  3. breast milk bioactive composition [ Time Frame: 1st year ]
    metabolite profile

  4. infant microbiota [ Time Frame: 1st year ]
    infant microbiota composition and diversity

  5. infant growth and development [ Time Frame: 1st year ]
    z-scores growth curves


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Women is Spain
Criteria

Inclusion Criteria:

  • Priority groups for coronavirus (COVID-19) vaccination (health and social care workers) following breastfeeding practices and receiving vaccines.

Exclusion Criteria:

  • cessation of breastfeeding and vaccine side-effects requiring specific treatment and/or hospitalization.
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04751734


Locations
Layout table for location information
Spain
Fundacion Investigacion Sanitaria INCLIVA
Valencia, Spain
Hospital Universitario y Politecnico la Fe
Valencia, Spain
Sponsors and Collaborators
Institute of Agrochemistry and Food Technology, National Research Council
Hospital Clínico Universitario de Valencia
Hospital Sant Joan de Deu
Hospital Universitario La Fe
Hospital Universitario Doctor Peset
Fundacion Para La Investigacion Hospital La Fe
Universitat Jaume I
University of Barcelona
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Layout table for additonal information
Responsible Party: Maria Carmen Collado, Researcher, Institute of Agrochemistry and Food Technology, National Research Council
ClinicalTrials.gov Identifier: NCT04751734    
Other Study ID Numbers: IATA-CSIC
First Posted: February 12, 2021    Key Record Dates
Last Update Posted: March 1, 2023
Last Verified: February 2023
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Maria Carmen Collado, Institute of Agrochemistry and Food Technology, National Research Council:
breast milk
microbiota
metabolites
immune compounds
growth and development
Additional relevant MeSH terms:
Layout table for MeSH terms
COVID-19
Respiratory Tract Infections
Infections
Pneumonia, Viral
Pneumonia
Virus Diseases
 Coronavirus Infections
Coronaviridae Infections
Nidovirales Infections
RNA Virus Infections
Lung Diseases
Respiratory Tract Diseases